Stay updated on Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.

Latest updates to the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision metadata now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This is an administrative update to the page versioning rather than a change to trial data or details.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s UI/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a platform release rather than a change to the study record itself.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check109 days agoChange DetectedAdded a new footer line 'Revision: v3.4.2' and removed the previous downtime/operating-status notice as well as the older 'Revision: v3.4.1' text.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.